ATE230262T1 - Lipidemulsionen mit optimierter hydrolyse sowie deren verwendung - Google Patents

Lipidemulsionen mit optimierter hydrolyse sowie deren verwendung

Info

Publication number
ATE230262T1
ATE230262T1 AT96939912T AT96939912T ATE230262T1 AT E230262 T1 ATE230262 T1 AT E230262T1 AT 96939912 T AT96939912 T AT 96939912T AT 96939912 T AT96939912 T AT 96939912T AT E230262 T1 ATE230262 T1 AT E230262T1
Authority
AT
Austria
Prior art keywords
pct
emulsions
lipide
hydrolysis
optimized
Prior art date
Application number
AT96939912T
Other languages
German (de)
English (en)
Inventor
German Pscherer
Marco Junginger
Joerg Nehne
Yvon A Carpentier
Original Assignee
Braun Melsungen Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7778601&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE230262(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Braun Melsungen Ag filed Critical Braun Melsungen Ag
Application granted granted Critical
Publication of ATE230262T1 publication Critical patent/ATE230262T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/60—Fish, e.g. seahorses; Fish eggs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/286—Carthamus (distaff thistle)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Botany (AREA)
  • Diabetes (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Dispersion Chemistry (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Obesity (AREA)
  • Nutrition Science (AREA)
  • Cardiology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Endocrinology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT96939912T 1995-11-28 1996-11-23 Lipidemulsionen mit optimierter hydrolyse sowie deren verwendung ATE230262T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19544310 1995-11-28
PCT/EP1996/005184 WO1997019683A1 (en) 1995-11-28 1996-11-23 Hydrolysis-optimized lipid emulsions and use thereof

Publications (1)

Publication Number Publication Date
ATE230262T1 true ATE230262T1 (de) 2003-01-15

Family

ID=7778601

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96939912T ATE230262T1 (de) 1995-11-28 1996-11-23 Lipidemulsionen mit optimierter hydrolyse sowie deren verwendung

Country Status (15)

Country Link
US (1) US6008248A (enExample)
EP (1) EP0863754B2 (enExample)
JP (1) JP4165904B2 (enExample)
CN (1) CN1259908C (enExample)
AT (1) ATE230262T1 (enExample)
AU (1) AU701736B2 (enExample)
BR (1) BR9611826A (enExample)
CA (1) CA2236422C (enExample)
CZ (1) CZ161898A3 (enExample)
DE (2) DE69625616T3 (enExample)
ES (1) ES2189891T5 (enExample)
MX (1) MX9804127A (enExample)
NZ (1) NZ322927A (enExample)
PL (1) PL186618B1 (enExample)
WO (1) WO1997019683A1 (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1090636A1 (en) * 1999-09-13 2001-04-11 Société des Produits Nestlé S.A. High lipid diet
US6946488B2 (en) * 2000-05-01 2005-09-20 The Iams Company Pet food composition for reducing inflammatory response in cats
EP1539104A4 (en) * 2000-12-29 2005-06-15 Univ Columbia USE OF IV EMULSIONS OF DIFFERENT TRIGLYCERIDE COMPOSITION, PARTICLE SIZE AND APOLIPOPROTEIN E FOR TARGETED TISSUE DELIVERY OF HYDROPHOBIC COMPOUNDS
EP1900364B1 (en) * 2001-04-18 2013-09-25 ProMetic BioSciences Inc. Medium-chain length fatty acids, glycerides and analogues as neutrophil survival and activation factors
EP1279400A1 (en) * 2001-07-25 2003-01-29 Target Hit sa Modifying the fatty acid composition of cell membranes of organs and tissues
US20030032674A1 (en) * 2001-08-13 2003-02-13 Hwang Daniel H. Use of unsaturated fatty acids to treat severe inflammatory diseases
ITMI20012384A1 (it) * 2001-11-12 2003-05-12 Quatex Nv Uso di acidi grassi poliinsaturi per la prevenzione primaria di eventi cardiovascolari maggiori
AU2002350353A1 (en) * 2001-12-27 2003-07-15 Genesis Group Inc. Seal oil based lipid emulsions and uses thereof
CA2496923A1 (en) * 2002-08-29 2004-03-11 University Of Massachusetts Utilization of emulsion interface engineering to produce oxidatively stable lipid delivery systems
US7323206B1 (en) 2003-03-04 2008-01-29 B. Braun Medical Inc. Reagents and methods for all-in-one total parenteral nutrition for neonates and infants
US8241672B2 (en) * 2009-03-11 2012-08-14 Stable Solutions Llc Omega-3 enriched fish oil-in-water parenteral nutrition emulsions
US20110071090A1 (en) * 2009-03-11 2011-03-24 Stable Solutions Llc Method of mitigating adverse drug events using omega-3-fatty acids as a parenteral therapeutic drug vehicle
US9034389B2 (en) 2009-03-11 2015-05-19 Stable Solutions Llc Omega-3 enriched fish oil-in-water parenteral nutrition emulsions
US8993625B2 (en) 2009-03-11 2015-03-31 Stable Solutions Llc Method of mitigating adverse drug events using omega-3 fatty acids as a parenteral therapeutic drug vehicle
EP2560633B8 (en) 2010-04-23 2020-08-12 The Government of the United States, as represented by The Secretary of the Army Intravenous omega-3 fatty acid compositions & method of use
CN106241871A (zh) * 2016-07-15 2016-12-21 攀钢集团攀枝花钢铁研究院有限公司 高浓度钒液酸性铵盐沉钒方法
CN117918525A (zh) 2017-08-10 2024-04-26 儿童医疗中心有限公司 与包含鱼油和/或ω-3脂肪酸的乳剂有关的方法和组合物
CN108498562B (zh) * 2018-04-08 2021-03-16 北京壹诺药业有限公司 具有抗疲劳抗肿瘤增强免疫的油脂乳状液及其应用
US20220040141A1 (en) * 2018-10-01 2022-02-10 Blue Harvest, Llc Ultrapure phenol compositions

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59172416A (ja) * 1983-03-18 1984-09-29 Terumo Corp 脂肪輸液
DE3721137A1 (de) * 1987-06-26 1989-01-05 Dietl Hans Fettemulsion zur intravenoesen anwendung
DE3722540A1 (de) * 1987-07-08 1989-01-19 Fresenius Ag Fettemulsion, verfahren zu ihrer herstellung und ihre verwendung
FR2618332B1 (fr) * 1987-07-23 1990-04-27 Synthelabo Emulsion lipidique destinee a la nutrition parenterale ou enterale
US5034415A (en) * 1987-08-07 1991-07-23 Century Laboratories, Inc. Treatment of diabetes mellitus
DE3734147C2 (de) * 1987-10-09 1998-10-29 Braun Melsungen Ag Isotone omega-3-fettsäurenhaltige Fettemulsion und ihre Verwendung
US5089268A (en) * 1990-05-02 1992-02-18 Katz David P Egg phosphatide lipid emulsions altered for a specific therapeutic fatty acid composition
US5470839A (en) * 1993-04-22 1995-11-28 Clintec Nutrition Company Enteral diet and method for providing nutrition to a diabetic
US5444054A (en) * 1994-04-01 1995-08-22 Abbott Labatories Method of treating ulcerative colitis
US5574065A (en) † 1994-04-21 1996-11-12 Clintec Nutrition Co. Method and composition for normalizing injury response

Also Published As

Publication number Publication date
AU701736B2 (en) 1999-02-04
CN1259908C (zh) 2006-06-21
ES2189891T3 (es) 2003-07-16
PL326929A1 (en) 1998-11-09
DE69625616T2 (de) 2003-11-06
EP0863754B2 (en) 2009-12-30
JP4165904B2 (ja) 2008-10-15
BR9611826A (pt) 1999-07-13
DE69625616D1 (de) 2003-02-06
DE69625616T3 (de) 2010-07-08
NZ322927A (en) 1999-06-29
EP0863754B1 (en) 2003-01-02
EP0863754A1 (en) 1998-09-16
CN1202823A (zh) 1998-12-23
CZ161898A3 (cs) 1998-11-11
US6008248A (en) 1999-12-28
CA2236422C (en) 2002-11-19
AU7697296A (en) 1997-06-19
PL186618B1 (pl) 2004-02-27
MX9804127A (es) 1998-12-31
DE19648566A1 (de) 1997-06-05
CA2236422A1 (en) 1997-06-05
JP2000500769A (ja) 2000-01-25
ES2189891T5 (es) 2010-04-27
WO1997019683A1 (en) 1997-06-05

Similar Documents

Publication Publication Date Title
ATE230262T1 (de) Lipidemulsionen mit optimierter hydrolyse sowie deren verwendung
DE69521338D1 (de) Öl-in-wasser-emulsionen
ES2116530T3 (es) Productos de cuidado personal que contienen silicona.
IT8521644A0 (it) Succinimmidi modificati particolarmente per additivi usati come disperdenti per oli lubrificanti e benzine.
BR0008177A (pt) Ëleos com comprimentos de cadeia heterogêneos
ES2216055T3 (es) Metodos para reducir o mantener niveles reducidos de lipidos en sangre usando composiciones de proteina ob.
CA2413105A1 (en) Recommending search terms using collaborative filtering and web spidering
DE60022503D1 (de) Verwendung von ölsäurereichen und stearinsäurereichen ölen
BR9509269A (pt) Processo para tratar diabetes
DE69308304D1 (de) Ölzusätze und zusammensetzungen
DE69409520D1 (de) Fettenschleimungsverfahren und so erhaltenes fett
KR950702223A (ko) 오일 첨가제 및 조성물(oil additives and compositions)
GR3032393T3 (en) Deoxygenation of an oil product with a laccase
ATE184638T1 (de) Ölzusammensetzungen
NO20001461D0 (no) Smøreevneadditiver for brennoljesammensetninger
FR2748730B3 (fr) Receptacle a dimensions variables
AR000928A1 (es) Método para obtener plantas transgenicas
ATE217153T1 (de) Verwendung von galactanase in tierfutter
NO981718D0 (no) Blanding for behandling av fjµrfe avfall
PT837775E (pt) Metodo para a producao de um laminado de embalagem com propriedades de barreira
Dhileepkumar et al. PAH Marks the Spot: Digging for Buried Clusters in Nearby Star-forming Galaxies-Ages and Extinctions for Embedded Clusters
Higginbotham et al. Internal slcerostomy with the Nd: YAG contact laser versus thermal sclerostomy in cynomolgus monkeys
AT5041U2 (de) Lipidhältige augentropfen als tränenersatzmittel
DK0601159T3 (da) Fremgangsmåde til ultrafiltrering af stabiliserede emulsioner
Brace " Set furth and put in print": Agency and print in sixteenth-century books by women.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties